Medicare Changes in Washington State

In Washington, individuals enrolled in Medicare might soon need extra approval for various medical procedures. This change comes as part of a pilot program that started on January 1 and involves states like Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington, utilizing artificial intelligence to assess coverage for certain services.

While participation for doctors is voluntary, some critics view this initiative as a significant step towards privatizing Medicare under the previous Trump administration. The use of AI in this process has raised concerns as well. Dr. Matt Hollon, representing the Washington Medical Association, expressed disappointment, stating, “Patients expect care to be guided by doctors, not insurance companies or automated systems.”

The Centers for Medicare and Medicaid Services (CMS) claim that the intent behind this pilot is to reduce fraud and wasteful spending within Medicare, which provides health insurance for those over 65 or younger individuals with disabilities. However, patient advocates, doctors, hospitals, and lawmakers in Washington worry that the new procedures may hinder access to necessary care due to complexities in the approval process.

The selection of Washington for this pilot raises questions, particularly as the CMS explained that including diverse states is essential for testing the model effectively. With approximately 1.6 million Medicare beneficiaries in Washington, split between traditional Medicare and Medicare Advantage, the implications are significant.

The new model aims to cut down on unnecessary services deemed too costly concerning their medical value. Procedures under scrutiny include skin and tissue replacements for osteoarthritis, treatments for impotence, and certain surgical procedures. Though aimed at avoiding excessive and unwarranted procedures, there are concerns that this could lead to broader restrictions in the future.

Senator Patty Murray from Washington labeled the initiative as a form of healthcare privatization and emphasized her opposition, stating, “I’m going to oppose every way I can in the Senate.”

Concerns extend to the involvement of third-party companies, which may have incentives to deny care based on the savings they generate. Dr. Hollon articulated that utilizing AI does not account for individual patient circumstances, potentially leading to denied care, countering the essence of healthcare delivery.

According to a CMS spokesperson, strict penalties are in place for illegal denials and any delays. Doctors willing to submit prior approval requests aim to secure payment before care is rendered, contrasting with the traditional prepayment review process they’re accustomed to.

Jeb Shepherd from the Medical Association described this pilot as a preliminary step towards advance approvals in traditional Medicare, hinting that it may not remain a voluntary endeavor.

Historically, Medicare Advantage plans have implemented such prior approvals more consistently than traditional Medicare, where they are seldom required. Many Medicare Advantage appeals have overturned denial decisions, yet countless patients remain unaware of their right to appeal.

Interest surrounding the prior approval issue has surged following high-profile events, including the death of a CEO from a major insurance company last year. Some companies involved in this pilot may overlap with those associated with the current review protocols of Medicare Advantage.

Just prior to this model’s launch, notable figures like Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz promoted efforts to streamline prior authorizations within the insurance industry, aiming for improved response times by 2027.

Hospital leaders are wary of how these changes may slow down patient care, as highlighted by Taya Briley from the Washington State Hospital Association. Similarly, Dr. Bindu Nayak pointed out that the added burdens of prior authorizations detract from time better spent with patients.

Tim Smolen, from the Washington Insurance Secretary’s Office, remained optimistic about the potential for clearer approval processes, while stressing the need for more straightforward communications with providers and beneficiaries.

Recently, U.S. lawmakers, led by Susan Delbene, pushed for clarification regarding the pilot, seeking transparency about its implementation. Many representatives, including Marilyn Strickland and Emily Randall, supported this initiative.

As of now, no response has been received from Oz regarding these inquiries.

Delbene emphasized the need for a bipartisan approach, underscoring the importance of ensuring access to care across different states, while also calling for a thorough understanding of the pilot’s structure and intentions.

AARP has indicated that they are observing the implementation closely, highlighting concerns surrounding Medicare fraud and the importance of guaranteeing healthcare for older citizens.

In response to these shifts, a bill in the Washington State Assembly aims to oversee the use of prior approvals and limit AI’s role in decision-making processes. While progress remains slow, it’s expected to be revisited in 2026 at the federal level.

Delbene also introduced a bipartisan bill aimed at expediting existing approval processes for Medicare Advantage subscribers, with added safeguards to ensure fair treatment.